Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

In their real-world study, Bajpai et al 7 expand our knowledge on the activity and safety of a combination presented as a novel metronomic regimen of vinblastine, methotrexate, and tamoxifen. They ...

Neurofibromatosis is a group of rare genetic disorders that cause benign tumors to form on nerve tissue. Tumors in this disorder are usually noncancerous (benign), but can sometimes become cancerous ...

New guidance on managing desmoid fibromatosis recommends a more conservative approach, encompassing the patient perspective, active surveillance, tumor location, and risk-benefit assessment. Outcomes ...

A rare genetic disorder known as Neurofibromatosis type one, or NF1, affects about one in 2,500 people in the U.S. That's about 120,000 people. Of those, half will develop a subtype--plexiform ...

Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer Desmoid tumors ...

In children and infants, the most common cardiac tumor after the rhabdomyoma is a fibroma. [17] In surgical series involving all age groups, fibroma is the second most common benign primary cardiac ...

SpringWorks Therapeutics announced that the European Medicine Agency’s Committee for Medicinal Products for Human Use has recommended the approval of nirogacestat, an oral gamma secretase inhibitor, ...

People plan to run around Comerica Park in their underwear on Saturday, Feb. 14, to raise money for neurofibromatosis research.